Yes. The FDA issued MEDVi, LLC a warning letter dated 20 February 2026, reference 721455, after reviewing its website in December 2025. The FDA objected to claims including "Same active ingredient as Wegovy® and Ozempic®" and "Same active ingredient as Mounjaro® and Zepbound®" as implying the compounded products had been FDA-approved or evaluated for safety and effectiveness when they had not, and found that pictured product labels bore the MEDVi name suggesting MEDVi was the compounder when it was not. The FDA concluded the products were misbranded drugs delivered into interstate commerce in violation of federal law. MEDVi was one of 30 telehealth companies to receive such letters. You can read it on the FDA warning letter database.

It is a real, operating company with LegitScript certification, licensed prescribers and a very large base of satisfied Trustpilot reviewers — roughly 4.4 out of 5 across more than 11,000 reviews. It is not a fake pharmacy. But "legitimate" and "well-run" are different questions, and on the second the public record is poor: an FDA warning letter for misbranding in February 2026, and an F rating from the BBB with 682 complaints and 100 of them unanswered.

Compounded semaglutide injections are $179 for the first month and $299/month afterwards. Compounded semaglutide tablets are $249 rising to $369. Compounded tirzepatide is $279 for the first month and $399/month afterwards. There is no separate membership fee, so the medication price is your whole cost — but the advertised figure is always a first-month rate, and the standing rate is what you should budget.

No. Earlier third-party reporting suggested a $99/month membership, which conflicted with MEDVi's own no-membership claim; current reporting resolves it in MEDVi's favour. The pricing complication here is not a hidden membership — it is the step up from the first-month rate to the standing rate.

Only under restrictive conditions. The money-back guarantee requires you to have followed the programme for at least five months, and the refund is issued less a 25% doctor consultation fee. Reporting indicates the requirement moved from three months to five. Separately, MEDVi's published policy states that if your subscription is charged two or more months at a time you will be refunded for months in which no medication shipped. Compounded medication is not returnable once dispensed.

Because they measure different things and draw different populations. Trustpilot collects reviews broadly, including solicited ones from satisfied customers, and MEDVi has a very large customer base. The BBB rating is driven by complaint handling — its profile records 682 complaints and states the company failed to respond to 100 of them, which is the stated reason for the F. A high satisfaction score and a large volume of unanswered disputes can coexist. If your transaction goes smoothly you will likely be happy; the question is what happens if it does not.

No, and this is precisely what the FDA warned MEDVi about. Compounded semaglutide shares an active ingredient with the branded products, but it is not FDA-approved and has not been evaluated by the FDA for safety, efficacy or quality. Sharing an active ingredient is not equivalence: the branded products went through clinical trials and FDA review, and the compounded copies did not. The FDA found MEDVi's "same active ingredient" framing misleading for implying otherwise.

Anyone uncomfortable with the regulatory record above, which we would suggest is most readers given that cheaper and better-documented alternatives exist. Anyone who may need responsive support or a refund. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Common side effects include nausea, vomiting, diarrhoea and constipation. A licensed clinician who knows your history should make that assessment.